Houston co. unveils Prada-designed spacesuit to be used on the moon

from catwalk to moonwalk

Axiom says the suit, which fits men and women, will enable astronauts to perform a spacewalk for at least eight hours. Photo courtesy of Axiom Space

Fashion met the future this week as Houston-based Axiom Space and the Prada apparel brand revealed the design of the spacesuit that NASA astronauts will wear during their upcoming journey to the moon.

Axiom, a space exploration company, and Prada, a fixture in the world of luxury fashion, debuted their design of the Axiom Extravehicular Mobility Unit (AxEMU) spacesuit at the International Astronautical Congress in Milan, Italy.

Set for 2026, NASA’s Artemis III mission will be the first “staffed” lunar landing since Apollo 17 in 1972. Four astronauts have been selected for the 30-day mission.

Components of the white, gray, and red spacesuit include:

Lights
HD camera
Cellular communications
“Endurance athlete”-style nutrition
Backpack with portable life support system
Custom-made gloves
Boots designed to withstand lunar temperatures and rough terrain

The spacesuit work is being performed under a nearly $1.3 billion NASA contract. Photo courtesy of Axiom Space

Axiom says the suit, which fits men and women, will enable astronauts to perform a spacewalk for at least eight hours. It’s geared toward lunar missions and low-earth-orbit missions.

“The AxEMU has significant advancements in safety, mobility, sizing, and performance,” the company says.

During development of the suit, Axiom placed a dark cover on the outer layer to conceal the suit’s proprietary technology. However, the suits worn on the lunar surface will be made from a white material that reflects heat, and protects astronauts from extreme high temperatures and lunar dust.

The spacesuit work is being performed under a nearly $1.3 billion NASA contract.

“Going beyond our limits is one of the company’s values that perfectly reflects the spirit of the Prada brand and my parents’ vision. I’m very proud of the result we’re showing today, which is just the first step in a long-term collaboration with Axiom Space,” Lorenzo Bertelli, Prada’s chief marketing officer and head of corporate social responsibility, says in a news release.

Axiom says the suit is near the final stage of development. Already, it has gone through testing by astronauts and engineers at Axiom, NASA, and SpaceX facilities. Among the tests were reduced-gravity simulations at NASA’s Johnson Space Center in Houston and underwater simulations at NASA’s Neutral Buoyancy Laboratory, also in Houston.

The suit will undergo an in-depth design review in 2025.

From Your Site Articles

Prada is collaborating with Houston-based aerospace company Axiom Space on the design of spacesuits for NASA’s Artemis III mission to the moon. Photo via axiomspace.com

Houston company collaborates with major fashion designer for spacesuit project

astronaut couture

Courtesy of the Prada luxury brand, NASA astronauts are getting an infusion of fashion.

Prada is collaborating with Houston-based aerospace company Axiom Space on the design of spacesuits for NASA’s Artemis III mission to the moon. Astronauts haven’t yet been chosen for the mission, which is set for 2025.

“Prada’s technical expertise with raw materials, manufacturing techniques, and innovative design concepts will bring advanced technologies instrumental in ensuring not only the comfort of astronauts on the lunar surface, but also the much-needed human factors considerations absent from legacy spacesuits,” says Michael Suffredini, co-founder, president, and CEO of Axiom Space.

The spacesuit, called the Axiom Extravehicular Mobility Unit (AxEMU), is geared toward improving astronauts’ flexibility, boosting protection against harsh conditions, and supplying tools for exploration and scientific activities.

“Our decades of experimentation, cutting-edge technology, and design know-how – which started back in the ’90s with Luna Rossa challenging for the America’s Cup – will now be applied to the design of a spacesuit for the Artemis era. It is a true celebration of the power of human creativity and innovation to advance civilization,” says Lorenzo Bertelli, marketing director of the Prada brand.

NASA has enlisted Axiom and Charlotte, North Carolina-based Collins Aerospace to outfit astronauts with next-generation spacesuits. Axiom’s partners on this project are KBR and Sophic Synergistics, both based in Houston, along with Air-Lock, A-P-T Research, Arrow Science and Technology, David Clark Co., and Paragon Space Development.

Collins maintains a sizable presence at the Houston Spaceport.

In July, Axiom secured a NASA task order potentially worth $147 million to modify the Artemis III spacesuit for astronauts heading to the International Space Station. This follows a $228 million NASA task order awarded to Axiom in 2022 for development of the Artemis III spacesuit.

The task orders are part of Axiom’s $1.26 billion spacesuit contract with NASA. All told, NASA has earmarked as much as $3.5 billion for new spacesuits.

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Rice University researchers unveil new model that could sharpen MRI scans

MRI innovation

Researchers at Rice University, in collaboration with Oak Ridge National Laboratory, have developed a new model that could lead to sharper imaging and safer diagnostics using magnetic resonance imaging, or MRI.

In a study recently published in The Journal of Chemical Physics, the team of researchers showed how they used the Fokker-Planck equation to better understand how water molecules respond to contrast agents in a process known as “relaxation.” Previous models only approximated how water molecules relaxed around contrasting agents. However, through this new model, known as the NMR eigenmodes framework, the research team has uncovered the “full physical equations” to explain the process.

“The concept is similar to how a musical chord consists of many notes,” Thiago Pinheiro, the study’s first author, a Rice doctoral graduate in chemical and biomolecular engineering and postdoctoral researcher in the chemical sciences division at Oak Ridge National Laboratory, said in a news release. “Previous models only captured one or two notes, while ours picks up the full harmony.”

According to Rice, the findings could lead to the development and application of new contrast agents for clearer MRIs in medicine and materials science. Beyond MRIs, the NMR relaxation method could also be applied to other areas like battery design and subsurface fluid flow.

“In the present paper, we developed a comprehensive theory to interpret those previous molecular dynamics simulations and experimental findings,” Dilipkumar Asthagiri, a senior computational biomedical scientist in the National Center for Computational Sciences at Oak Ridge National Laboratory, said in the release. ”The theory, however, is general and can be used to understand NMR relaxation in liquids broadly.”

The team has also made its code available as open source to encourage its adoption and further development by the broader scientific community.

“By better modeling the physics of nuclear magnetic resonance relaxation in liquids, we gain a tool that doesn’t just predict but also explains the phenomenon,” Walter Chapman, a professor of chemical and biomolecular engineering at Rice, added in the release. “That is crucial when lives and technologies depend on accurate scientific understanding.”

The study was backed by The Ken Kennedy Institute, Rice Creative Ventures Fund, Robert A. Welch Foundation and Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory.

Houston-area lab grows with focus on mobile diagnostics and predictive medicine

mobile medicine

When it comes to healthcare, access can be a matter of life and death. And for patients in skilled nursing facilities, assisted living or even their own homes, the ability to get timely diagnostic testing is not just a convenience, it’s a necessity.

That’s the problem Principle Health Systems (PHS) set out to solve.

Founded in 2016 in Clear Lake, Texas, PHS began as a conventional laboratory but quickly pivoted to mobile diagnostics, offering everything from core blood work and genetic testing to advanced imaging like ultrasounds, echocardiograms, and X-rays.

“We were approached by a group in a local skilled nursing facility to provide services, and we determined pretty quickly there was a massive need in this area,” says James Dieter, founder, chairman and CEO of PHS. “Turnaround time is imperative. These facilities have an incredibly sick population, and of course, they lack mobility to get the care that they need.”

What makes PHS unique is not only what they do, but where they do it. While they operate one of the largest labs serving skilled nursing facilities in the state, their mobile teams go wherever patients are, whether that’s a nursing home, a private residence or even a correctional facility.

Diagnostics, Dieter says, are at the heart of medical decision-making.

“Seventy to 80 percent of all medical decisions are made from diagnostic results in lab and imaging,” he says. “The diagnostic drives the doctor’s or the provider’s next move. When we recognized a massive slowdown in lab results, we had to innovate to do it faster.”

Innovation at PHS isn’t just about speed; it’s about accessibility and precision.

Chris Light, COO, explains: “For stat testing, we use bedside point-of-care instruments. Our phlebotomists take those into the facilities, test at the bedside, and get results within minutes, rather than waiting days for results to come back from a core lab.”

Scaling a mobile operation across multiple states isn’t simple, but PHS has expanded into nine states, including Texas, Oklahoma, Kansas, Missouri and Arizona. Their model relies on licensed mobile phlebotomists, X-ray technologists and sonographers, all trained to provide high-level care outside traditional hospital settings.

The financial impact for patients is significant. Instead of ambulance rides and ER visits costing thousands, PHS services often cost just a fraction, sometimes only tens or hundreds of dollars.

“Traditionally, without mobile diagnostics, the patient would be loaded into a transportation vehicle, typically an ambulance, and taken to a hospital,” Dieter says. “Our approach is a fraction of the cost but brings care directly to the patients.”

The company has also embraced predictive and personalized medicine, offering genetic tests that guide medication decisions and laboratory tests that predict cognitive decline from conditions like Alzheimer's and Parkinson’s.

“We actively look for complementary services to improve patient outcomes,” Dieter says. “Precision medicine and predictive testing have been a great value-add for our providers.”

Looking to the future, PHS sees mobile healthcare as part of a larger trend toward home-based care.

“There’s an aging population that still lives at home with caretakers,” Dieter explains. “We go into the home every day, whether it’s an apartment, a standalone home, or assisted living. The goal is to meet patients where they are and reduce the need for hospitalization.”

Light highlighted another layer of innovation: predictive guidance.

“We host a lot of data, and labs and imaging drive most treatment decisions,” Light says. “We’re exploring how to deploy diagnostics immediately based on results, eliminating hours of delay and keeping patients healthier longer.”

Ultimately, innovation at PHS isn’t just about technology; it’s about equity.

“There’s an 11-year life expectancy gap between major metro areas and rural Texas,” Dieter says. “Our innovation has been leveling the field, so everyone has access to high-quality diagnostics and care, regardless of where they live.”

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME